Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The frequent lack of a microbiological diagnosis in community-acquired pneumonia (CAP) impairs pathogen-directed antimicrobial therapy. This study assessed the use of comprehensive multibacterial, multiviral molecular testing, including quantification, in adults hospitalized with CAP. METHODS: Clinical and laboratory data were collected for 323 adults with radiologically-confirmed CAP admitted to 2 UK tertiary care hospitals. Sputum (96%) or endotracheal aspirate (4%) specimens were cultured as per routine practice and also tested with fast multiplex real-time polymerase-chain reaction (PCR) assays for 26 respiratory bacteria and viruses. Bacterial loads were also calculated for 8 bacterial pathogens. Appropriate pathogen-directed therapy was retrospectively assessed using national guidelines adapted for local antimicrobial susceptibility patterns. RESULTS: Comprehensive molecular testing of single lower respiratory tract (LRT) specimens achieved pathogen detection in 87% of CAP patients compared with 39% with culture-based methods. Haemophilus influenzae and Streptococcus pneumoniae were the main agents detected, along with a wide variety of typical and atypical pathogens. Viruses were present in 30% of cases; 82% of these were codetections with bacteria. Most (85%) patients had received antimicrobials in the 72 hours before admission. Of these, 78% had a bacterial pathogen detected by PCR but only 32% were culture-positive (P < .0001). Molecular testing had the potential to enable de-escalation in number and/or spectrum of antimicrobials in 77% of patients. CONCLUSIONS: Comprehensive molecular testing significantly improves pathogen detection in CAP, particularly in antimicrobial-exposed patients, and requires only a single LRT specimen. It also has the potential to enable early de-escalation from broad-spectrum empirical antimicrobials to pathogen-directed therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 2,323
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
Jain, S., Williams, D. J., Arnold, S. R., Ampofo, K., Bramley, A. M., Reed, C., Stockmann, C., Anderson, E. J., Grijalva, C. G., Self, W. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405870 · Cited by 1,804
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
Lim, W. S., Baudouin, S. V., George, R. C., Hill, A. T., Jamieson, C., Le Jeune, I., Macfarlane, J. T., Read, R. C., Roberts, H. J., Levy, M. L., et al. (2009) · Thorax · doi:10.1136/thx.2009.121434 · Cited by 1,420
Self-citationRapid and quantitative detection of human adenovirus DNA by real‐time PCR
Heim, A., Ebnet, C., Harste, G., & Pring‐Åkerblom, P. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10382 · Cited by 820
Gaunt, E. R., Hardie, A., Claas, E. C. J., Simmonds, P., & Templeton, K. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00636-10 · Cited by 699
Self-citationMusher, D. M., & Thorner, A. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312885 · Cited by 626
Cited by
Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns
Cilloniz, C., Martin-Loeches, I., Garcia-Vidal, C., San Jose, A., & Torres, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122120 · Cited by 291
Etiology of community-acquired pneumonia in adults: a systematic review
Shoar, S., & Musher, D. M. (2020) · Pneumonia · doi:10.1186/s41479-020-00074-3 · Cited by 273
Burden of Community-Acquired Pneumonia and Unmet Clinical Needs
Ferreira-Coimbra, J., Sarda, C., & Rello, J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01248-7 · Cited by 255
Antimicrobial-associated harm in critical care: a narrative review
Arulkumaran, N., Routledge, M., Schlebusch, S., Lipman, J., & Conway Morris, A. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05929-3 · Cited by 175
Hanson, K. E., & Couturier, M. R. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw494 · Cited by 99
Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology Patients
Legoff, J., Zucman, N., Lemiale, V., Mokart, D., Pène, F., Lambert, J., Kouatchet, A., Demoule, A., Vincent, F., Nyunga, M., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201804-0681oc · Cited by 80
Abbott, A. N., & Fang, F. C. (2017) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2017.08.004 · Cited by 13
Metadata
- Authors
- Gadsby, N. J., Russell, C. D., McHugh, M. P., Mark, H., Conway Morris, A., Laurenson, I. F., Hill, A. T., & Templeton, K. E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-07
- Volume
- 62
- Issue
- 7
- Pages
- 817-823
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2295398066
- Cited by
- 446
- References
- 37
- FWCI
- 36.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.